- Home
- GNTX vs KYMR Comparison
GNTX vs KYMR Comparison
Compare GNTX & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNTX | KYMR |
|---|---|---|
| Founded | 1974 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.7B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GNTX | KYMR |
|---|---|---|
| Price | $22.95 | $67.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 19 |
| Target Price | $29.00 | ★ $69.58 |
| AVG Volume (30 Days) | ★ 2.4M | 731.3K |
| Earning Date | 10-24-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.70 | N/A |
| Revenue | ★ $2,431,504,922.00 | $43,735,000.00 |
| Revenue This Year | $11.92 | $60.88 |
| Revenue Next Year | $4.94 | N/A |
| P/E Ratio | $13.44 | ★ N/A |
| Revenue Growth | ★ 3.00 | N/A |
| 52 Week Low | $20.28 | $19.45 |
| 52 Week High | $31.25 | $68.80 |
Technical Indicators
Market Signals| Indicator | GNTX | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 41.73 | 67.89 |
| Support Level | $21.69 | $63.86 |
| Resistance Level | $22.54 | $68.44 |
| Average True Range (ATR) | 0.44 | 3.37 |
| MACD | 0.15 | 0.19 |
| Stochastic Oscillator | 60.90 | 89.48 |
Price Performance
Historical ComparisonAbout GNTX Gentex Corporation
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.